Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
暂无分享，去创建一个
Jing Wang | L. Byers | F. Ciardiello | T. Troiani | C. D. Della Corte | G. Viscardi | G. Martini | D. Ciardiello | E. Martinelli | F. Morgillo | L. Diao | C. Gay | M. Fasano | S. Napolitano | R. Cardnell | F. Cimmino | C. Tuccillo | V. Famiglietti | R. Di Liello | V. Ciaramella | K. Ramkumar